---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000071"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:33:43.742588+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lifecore CEO James Hall resigns; Paul Josephs appointed CEO and director effective May 20

## Summary
- James G. Hall resigned as director, President and CEO effective May 19, 2024.
- Paul Josephs appointed President, CEO and director effective May 20, 2024.
- Josephs previously CEO of Woodstock Sterile Solutions (CDMO) from April 2021 to May 2024.
- Granted 525,000 RSUs (25k vested immediately, 100k/year over 5 years) and up to 1.5M PSUs with performance price targets from $7.50 to $35.00 per share.
- Josephs enters Tier 1 Change in Control Severance Plan benefits.

## SEC filing metadata
- accession: 0001005286-24-000071
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/lndc-20240519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000071
- JSON: https://secwatch.observer/filing/0001005286-24-000071.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000071.txt

## Key facts
- Executive change
  James G. Hall resigned as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: Effective May 19, 2024, James G. Hall resigned as a director of the Company and ceased serving as the Company’s President and Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm
- Executive change
  Paul Josephs was appointed as President and Chief Executive Officer at LIFECORE BIOMEDICAL, INC. DE.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On May 20, 2024, Paul Josephs began serving as the Company’s President and Chief Executive Officer and was elected as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000071/0001005286-24-000071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.